Skip to content
Disclosery

MPM ASSET MANAGEMENT LLC

Follow

13F filer, CIK 1263048, BOSTON, MA

MPM ASSET MANAGEMENT LLC reported $145,272,770 across 6 holdings for the quarter ended 2024-09-30, in a 13F-HR filed 2024-11-13.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-24-011020

Period
2024-09-30
Reported value
$145M
Holdings
6
Top 10 weight
100%
New
0
Sold out
0

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
DYNreduced-879,120-$31.6M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2024

Share positions as resolved from 13F-HR 0000950123-24-011020, largest first. % of portfolio is the value over $145,272,770, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
TRDAENTRADA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 4,425,784 shares; 2024Q1: 4,425,784 shares; 2024Q2: 4,425,784 shares; 2024Q3: 4,425,784 shares 4,425,784$70.7M48.68%0Timeline
ITEOS THERAPEUTICS INCITEOS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 2,738,785 shares; 2024Q1: 2,738,785 shares; 2024Q2: 2,738,785 shares; 2024Q3: 2,738,785 shares 2,738,785$28M19.25%0
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 4,951,303 shares; 2024Q1: 3,451,303 shares; 2024Q2: 1,561,496 shares; 2024Q3: 682,376 shares 682,376$24.5M16.87%-879,120Timeline
HOWLWEREWOLF THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 4,284,172 shares; 2024Q1: 4,284,172 shares; 2024Q2: 4,284,172 shares; 2024Q3: 4,284,172 shares 4,284,172$9.08M6.25%0Timeline
REPARE THERAPEUTICS INCREPARE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 2,242,636 shares; 2024Q1: 2,242,636 shares; 2024Q2: 2,242,636 shares; 2024Q3: 2,242,636 shares 2,242,636$7.71M5.31%0
ADAPYADAPTIMMUNE THERAPEUTICS PLC SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 5,555,461 shares; 2024Q1: 5,555,461 shares; 2024Q2: 5,555,461 shares; 2024Q3: 5,555,461 shares 5,555,461$5.28M3.63%0Timeline

How Q3 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950123-24-011020 base2024-11-13acceptance time not in the bulk data set